Anatomic Stage IV Breast Cancer AJCC v8 Not Yet Recruiting Phase 2 Trials for Ceralasertib (DB14917)

IndicationStatusPhase
DBCOND0109665 (Anatomic Stage IV Breast Cancer AJCC v8)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04090567Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerTreatment